ClinicalTrials.gov
public full text
Public Domain
Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers
The purpose of this alcohol-interaction pilot study is to provide information on the effect of AZD0530 (Saracatinib) on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of a single dose of AZD0530 (125 mg) on alcohol related responses. This is a within subjects open label study in which the investigators plan to run 8 subjects to obtain 5 completers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Saracatinib and Alcohol Drinking#900171
- AZD2066 Cocktail Study#806899
- Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism#1059288
- Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence#1010534
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study#899066
Record · ID 1047324
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive